Ocugen (OCGN) Stock Statistics & Valuation Metrics

Ocugen has a market cap or net worth of $544.31M. The enterprise value is $557.92M.

Ocugen has 327,897,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ocugen’s return on equity (ROE) is 5.58 and return on invested capital (ROIC) is -278.62%.

The current PE Ratio of Ocugen is ―. Ocugen’s PEG ratio is -0.40.

In the last 12 months, Ocugen had revenue of 4.41M and earned -67.85M in profits. Earnings per share was -0.23.

In the last 12 months, operating cash flow was -56.96M and capital expenditures -185.00K, giving a free cash flow of -57.15M billion.

Ocugen pays an annual dividend of ―, resulting in a dividend yield of ―

Ocugen upcoming earnings date is May 1, 2026, Before Open (Confirmed).

Ocugen as a current ratio of 1.06, with Debt / Equity ratio of -272.43%

In the past 12 months, Ocugen has paid 0.00 in taxes.

Ocugen EV to EBITDA ratio is -6.94, with an EV/FCF ratio of -7.35.

Ocugen has $18.57M in cash and marketable securities with $33.14M in debt, giving a net cash position of -$14.57M billion.

Gross margin is 45.86%, with operating margin of -1425.70%, and net profit margin of -1537.41%.

The average price target for Ocugen is $7.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy